12.52 USD
▲+0.44+3.05%
2026-08-03
市值
$430.12M
市盈率
—
EPS
-0.93
股息率
—
52 周区间
9.85 – 16.76
成交量
64.83K
Beta
0.25
目标价
25.80
52W 低 9.8552W 高 16.76
价格走势
公司简介
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disea...